West Pharmaceutical Services Inc (WST) stock
WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3031% above fair value
$414.12−3.68 (-0.88%)
Close on Nov 17, 2026Market cap $28.85BP/E 46.5Yield 0.21%
West Pharmaceutical Services operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
West Pharmaceutical Services's operating cash flow for the twelve months ending Sep 30, 2026 was $654.50M, down 5.7% year over year. For fiscal 2025 it was $754.80M, up 15.5% from the year before. Over ten years it grew 13.5% a year on average. The highest annual figure on record is $776.50M in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $754.80M | +15.5% |
| FY2024 | Dec 31, 2024 | $653.40M | -15.9% |
| FY2023 | Dec 31, 2023 | $776.50M | +7.3% |
| FY2022 | Dec 31, 2022 | $724.00M | +24.0% |
| FY2021 | Dec 31, 2021 | $584.00M | +23.6% |
| FY2020 | Dec 31, 2020 | $472.50M | +28.7% |
| FY2019 | Dec 31, 2019 | $367.20M | +27.2% |
| FY2018 | Dec 31, 2018 | $288.60M | +9.6% |
| FY2017 | Dec 31, 2017 | $263.30M | +20.0% |
| FY2016 | Dec 31, 2016 | $219.40M | +3.3% |
| FY2015 | Dec 31, 2015 | $212.40M | +16.1% |
| FY2014 | Dec 31, 2014 | $182.90M | -17.1% |
| FY2013 | Dec 31, 2013 | $220.50M | +17.7% |
| FY2012 | Dec 31, 2012 | $187.40M | +43.4% |
| FY2011 | Dec 31, 2011 | $130.70M | -5.5% |
| FY2010 | Dec 31, 2010 | $138.30M | +0.4% |
| FY2009 | Dec 31, 2009 | $137.70M | +2.0% |
| FY2008 | Dec 31, 2008 | $135.00M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $189.50M | -3.9% |
| Q2 FY2026 | Jun 30, 2026 | $124.00M | -30.0% |
| Q1 FY2026 | Mar 31, 2026 | $89.90M | -30.5% |
| Q4 FY2025 | Dec 31, 2025 | $251.10M | +32.1% |
| Q3 FY2025 | Sep 30, 2025 | $197.20M | +9.5% |
| Q2 FY2025 | Jun 30, 2025 | $177.10M | +7.3% |
| Q1 FY2025 | Mar 31, 2025 | $129.40M | +9.5% |
| Q4 FY2024 | Dec 31, 2024 | $190.10M | -20.5% |
| Q3 FY2024 | Sep 30, 2024 | $180.10M | -21.7% |
| Q2 FY2024 | Jun 30, 2024 | $165.00M | -2.5% |
| Q1 FY2024 | Mar 31, 2024 | $118.20M | -14.4% |
| Q4 FY2023 | Dec 31, 2023 | $239.10M | +3.6% |
| Q3 FY2023 | Sep 30, 2023 | $230.10M | +36.2% |
| Q2 FY2023 | Jun 30, 2023 | $169.20M | -2.3% |
| Q1 FY2023 | Mar 31, 2023 | $138.10M | -8.7% |
| Q4 FY2022 | Dec 31, 2022 | $230.80M | +43.5% |
| Q3 FY2022 | Sep 30, 2022 | $168.90M | -11.2% |
| Q2 FY2022 | Jun 30, 2022 | $173.10M | +19.9% |
| Q1 FY2022 | Mar 31, 2022 | $151.20M | +70.5% |
| Q4 FY2021 | Dec 31, 2021 | $160.80M | +8.1% |
| Q3 FY2021 | Sep 30, 2021 | $190.10M | +60.3% |
| Q2 FY2021 | Jun 30, 2021 | $144.40M | -2.5% |
| Q1 FY2021 | Mar 31, 2021 | $88.70M | +55.3% |
| Q4 FY2020 | Dec 31, 2020 | $148.70M | +39.8% |
| Q3 FY2020 | Sep 30, 2020 | $118.60M | +9.7% |
| Q2 FY2020 | Jun 30, 2020 | $148.10M | +40.9% |
| Q1 FY2020 | Mar 31, 2020 | $57.10M | +20.0% |
| Q4 FY2019 | Dec 31, 2019 | $106.40M | +45.4% |
| Q3 FY2019 | Sep 30, 2019 | $108.10M | +22.3% |
| Q2 FY2019 | Jun 30, 2019 | $105.10M | +28.2% |
| Q1 FY2019 | Mar 31, 2019 | $47.60M | +5.8% |
| Q4 FY2018 | Dec 31, 2018 | $73.20M | -10.2% |
| Q3 FY2018 | Sep 30, 2018 | $88.40M | +16.6% |
| Q2 FY2018 | Jun 30, 2018 | $82.00M | -3.9% |
| Q1 FY2018 | Mar 31, 2018 | $45.00M | +117.4% |
| Q4 FY2017 | Dec 31, 2017 | $81.50M | +13.5% |
| Q3 FY2017 | Sep 30, 2017 | $75.80M | – |
| Q2 FY2017 | Jun 30, 2017 | $85.30M | – |
| Q1 FY2017 | Mar 31, 2017 | $20.70M | – |
| Q4 FY2016 | Dec 31, 2016 | $71.80M | – |
See a number that looks wrong?